Closed Loop Medicine is a Tech Bio company developing prescription combination drugs software products, to bring forward the promise of precision medicine.
We're thrilled to announce that our study, describing the breakthrough results of the PERSONAL-CovidPB clinical trial, has been published in @JAHA_AHA.
Read the full press release to learn how we're using these data: closedloopmedicine.com/close…
We have been selected to join #NVIDIAinception, an accelerator program led by world-leading AI Computing company, @nvidia, designed to nurture startups and early-stage companies revolutionizing industries with technological advancements. Read more: tinyurl.com/29pfme5b
.@AmDiabetesAssn returns for its 84th Annual Scientific Session on June 21st! #ADA2024
Arrange a meeting with @hakim_yadi to discuss how we are facilitating personalized disease management to improve the effectiveness of medicines, such as GLP-1s: shorturl.at/fMcea
In this interview with @EBRmagazine our CEO @hakim_yadi shared his insights on the global impact of mismanaged #hypertension, current healthcare limitations, and how novel technology applications and personalized dosing can revolutionize treatment, p.39-41 rb.gy/qpop3q
In this @INVIVOnow podcast, our CEO @Hakim_Yadi discussed how Closed Loop Medicine’s approach in pairing software as a medical device with advanced analytics and drugs can enhance personalized care across multiple therapeutic areas. Listen here: rb.gy/kdb1jg
Today we welcome Paul Johnson to the Board as a Non-Executive Director. With extensive experience in digital #healthcare and e-commerce, Paul joins to support the commercialization strategy for our integrated #precision care solutions: rb.gy/whm531
Tomorrow is #WorldHypertensionDay. Together with Pharmanovia, we are excited to announce the first patient recruitment and of a study investigating personalized dose management of an anti-hypertensive in improving blood pressure control.
COR2024SM00107
Date Prepared: May 2024
The #PrixGalien UK Forum returns on May 30, celebrating excellence in medical research. Attending as a panelist is our CEO, @Hakim_Yadi for the session titled, “Introducing new technologies: optimising pathways to improve population health.” prixgalien.co.uk
Curious about how #translationalscience can bridge the gap between basic research and clinical applications? Join our CEO @hakim_yadi at @lifearc1’s Translational Science Summit for an insightful day of exploration and discovery.
For more info visit: translationalsciencesummit.o…
Watch this video abstract outlining our clinical trial findings in @JAHA_AHA, which validate the use of our proprietary technology for the identification of a personalized dose regimen for the management of #hypertension: rb.gy/h4udx4
Have you listened to @BioCentury’s This Week podcast, where @jeff_cranmer and @StephenPHansen discuss our precision care approach for enhancing the tolerance and efficacy of obesity treatments without limiting market size.
Listen to the episode here: shorturl.at/cFGV7
“What we’re saying is there’s an opportunity to use real-time, real-world PK/PD to personalize dosing of products like GLP-1s.” - @hakim_yadi, @Closed_Loop_Med
Discover strategies for precision medicine in tackling obesity without market size limits: ow.ly/KX6o50QP08M